BeiGene, Ltd BGNE

EPSMomentum Premium

The PEAD projected a Bearish outlook for $BGNE after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 66.67%.

EPSMomentum Premium

The PEAD projected a Bullish outlook for $BGNE after a Negative under reaction following its earnings release placing the stock in drift D with an expected accuracy of 80%.

EPSMomentum Premium

The PEAD projected a Bullish outlook for $BGNE after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 100%.

RocketTickers

BGNE: BeiGene, Ltd. 2021-07-29 20:00:00 BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA Trial Comparing BRUKINSA® (Zanubrutinib) to Bendamustine Plus Rituximab in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia

el_Liverfin

Ascending triangle + bull close, strong setup and very fire

sojohnnysaid

Let's see if this pans out

jiucai_pingfanzhilu

BGNE short above 260$, target price 161$, about Mar 9, 2021. Similar pattern of Aug 8, 2018. Wait BGNE price reached 161$, start building long position. It's not a good idea holding BGNE under 270$~260$ Long stop-Loss price : 259$ Short stop-loss price : 284$

Minllion

BGNE 8/22

andrewztrade Updated 

We will trade long in the range $140 - 150 amid to gap overlap. Target will be $190 / 200. (+30% potentially)

superkumar2020 Updated 

buy only above 166.25 target 173.25 target 180.25 sl:162.25

lousyjets Premium

Making a nice inverse h&s and this has potential of going lot higher. Need to identify which strike. I am not even sure if I will pull the trigger but hopefully someone can find this helpful. Checked the options and look expensive. r/r is not attractive imho.

WaverVanir Premium

Down.

alfredalcasid

BGNE had a huge gain today of 10.5% after the market turned down towards the end of the day on weak volume. On the other hand, BGNE rocketed on 47% above average volume (20). Going along with this - During the recent weeks of the market correction, BGNE just barely went under the 21 day EMA and is still continually producing good earnings quarter after quarter....

WaverVanir Premium Updated 

We really want to enter this trade, but like always we make our plan first waite for the stock to hit a certain point and buy a massive amount of options for an easy 100%. St. Is bullish and Gan is confirming :D

alfredalcasid

Saucer on from Oct 10 to Mid January. Heavy volume on January 18 due to an offering. 1.18.18 - BGNE teamed up with CELG, receiving rights to market CELG's drugs in China for the next 10 years. BGNE acquired $750m from the offering which looks positive for new R&D of their drugs. Further analysis: Failed breakout at the 120 range on weak volume. Choppy...

Kareim

With upwards oscillators and heavy buy-back akin to situation on July. Possibly creating new resistance above $118 created October 10.